Home / Conditions / Type 1 Diabetes (page 6)

Type 1 Diabetes

Type 1 Diabetes Treatment and Research: Type 1 diabetes is an autoimmune disorder that destroys pancreatic beta cells. Once called juvenile diabetes, Type 1 is diagnosed most often in children, but can be expressed in adults as well. Incidence is highest among non-hispanic whites, according to the NDEP. Adults with Type 1 make up 5% of all diagnosed diabetes patients.New tools, techniques, treatments, drugs and devices can help you improve outcomes for your patients with Type 1.

Why High-Intensity Exercise Can Spike Blood Sugar in Diabetes

Athlete performing intense exercise while checking elevated blood sugar levels on a glucose monitor in a gym setting

A patient finishes a hard workout, checks their glucose monitor, and feels completely confused. Instead of seeing lower blood sugar after exercise, the reading is suddenly much higher. While this reaction may seem alarming, it is actually a common response to intense physical activity in people with diabetes. Certain workouts …

Read More »

Diabulimia in Type 1 Diabetes: The Warning Signs Clinicians Often Miss

Young woman with type 1 diabetes appearing emotionally distressed beside diabetes supplies and healthy food, representing warning signs associated with diabulimia treatment challenges.

Patients with type 1 diabetes already face the daily burden of balancing insulin, food intake, exercise, and glucose monitoring. However, for some individuals, insulin becomes more than a treatment tool. It becomes a method for weight control. This dangerous behavior, commonly referred to as diabulimia, involves the intentional restriction or …

Read More »

Misdiagnosed as Type 2? Why We Need to Screen More Adults for LADA

Doctor explaining LADA diabetes screening to an adult patient previously diagnosed with type 2 diabetes during a clinical consultation.

Up to 10% of adults diagnosed with type 2 diabetes may actually have Latent Autoimmune Diabetes in Adults (LADA), yet many cases remain undetected for years. Because symptoms often develop slowly, LADA is frequently mistaken for traditional type 2 diabetes. However, the wrong diagnosis can delay insulin therapy, worsen glucose …

Read More »

Ultra-Rapid Insulin and Automated Delivery: Are Mealtime Boluses Becoming Less Critical?

Person using an automated insulin delivery system with ultra-rapid insulin during a meal while monitoring glucose levels on a smartphone app.

For years, diabetes care has relied on one key rule: insulin should be given before meals whenever possible. Yet many people living with diabetes still struggle with timing. Busy schedules, unpredictable eating habits, and delayed dosing often lead to postprandial glucose spikes. Now, with the rise of ultra-rapid insulin AID …

Read More »

The Rise of “Double Diabetes”: Why More Adults With Type 1 Diabetes Are Developing Insulin Resistance

Adult with type 1 diabetes checking blood sugar levels alongside obesity and insulin resistance health concepts

More adults living with type 1 diabetes are now developing obesity, insulin resistance, hypertension, and metabolic complications once linked mainly to type 2 diabetes. This growing overlap, often called double diabetes, is becoming a major concern for clinicians and patients alike. While insulin therapy remains essential for type 1 diabetes …

Read More »

Open-Source Diabetes Technology Is Entering the Mainstream: Are Clinicians Ready?

Clinician discussing open-source diabetes technology and DIY insulin automation with a patient using a continuous glucose monitor and insulin pump.

The conversation around DIY diabetes technology and patient-led insulin automation has changed dramatically over the past few years. What once existed on the margins of diabetes care is now gaining recognition from major medical organizations and healthcare providers. In fact, the 2026 American Diabetes Association (ADA) Standards of Care continue …

Read More »

The New Pregnancy Tech Era in Diabetes: How Automated Insulin Delivery Is Expanding Into Maternal Care

Pregnant woman using an automated insulin delivery system and continuous glucose monitor to manage type 1 diabetes during pregnancy

The management of type 1 diabetes during pregnancy is entering a major turning point. For years, endocrinologists and maternal-fetal medicine specialists have worked within narrow therapeutic margins to reduce maternal and neonatal complications. However, new advances in automated insulin delivery technology for pregnancy are beginning to reshape glucose management in …

Read More »

Diabetes Burnout Is Rising in the Age of Always-On Technology

Woman with diabetes appearing emotionally exhausted while using CGM and insulin technology amid digital health alerts and glucose monitoring devices

A glucose alarm goes off during dinner. Another alert appears at 2 a.m. A smartphone app flashes warnings about rising blood sugar before the day even starts. Diabetes technology promises better control, yet for some patients, the nonstop stream of notifications and health data can feel mentally exhausting. Clinicians are …

Read More »

Continuous Ketone Monitoring Is Coming Fast: Can It Actually Reduce Outpatient DKA Risk?

Patient wearing a continuous ketone monitoring sensor while reviewing real-time glucose and ketone data on a smartphone app designed to help detect rising DKA risk.

New advances in diabetes technology are moving beyond glucose alone. While continuous glucose monitoring transformed diabetes management over the last decade, wearable ketone monitoring systems are now emerging as the next major innovation. Researchers, device manufacturers, and international diabetes organizations are increasingly focused on whether real-time ketone data can help …

Read More »

The FDA’s New Insulin Switching Rules: What Interchangeable Biosimilars Mean for Diabetes Care

Insulin pens beside an FDA symbol and prescription form representing interchangeable insulin biosimilars and pharmacy-level insulin switching in diabetes care.

A patient arrives at the pharmacy expecting their usual insulin refill, only to discover the box, brand name, and pen device suddenly look different. The pharmacist explains that the medication is an interchangeable biosimilar approved for automatic substitution. Although the insulin is considered clinically equivalent, the unexpected switch can still …

Read More »